名称 | PD153035 hydrochloride |
描述 | PD153035 hydrochloride (ZM 252868) is a effective and selective inhibitor of EGFR (Ki: 5.2 pM, IC50: 29 pM); few influence against FGFR, PGDFR, InsR, CSF-1, and Src. |
细胞实验 | Cells are seeded in sixwell plates. The next day, cells are changed to medium containing 0.5% FBS for 18 hours, and then PD153035 is added at various concentrations to the cultures. After 72 hours of treatment, cells are washed once with PBS, harvested with 0.1% human trypsin-l mM EDTA in PBS, and counted with a Coulter counter. The CMK cells grow in suspension and, therefore, do not require trypsinization.(Only for Reference) |
激酶实验 | Inhibition of EGF receptor tyrosine kinase : Enzyme reactions are performed in a total volume of 0.1 mL containing 25 mM Hepes (pH 7.4), 5 mM MgCl2, 2 mM MnCl2, 50 μM sodium vanadate, 0.5 to 1.0 ng of enzyme (which also contains enough EGF to make the final concentrations 2 μg/mL), 10 μM ATP containing 1 μCi of [32P]ATP, varying concentrations of PD153035, and 200 μM of a substrate peptide based on a portion of phospholipase C-γl having the sequence Lys-His-Lys-Lys-Leu-Ala-Glu-Gly-Ser-Ala-Tyr472-Glu-Glu-Val. The reaction is initiated by the addition of ATP. After 10 minutes at room temperature, the reaction is terminated by addition of 2 mL of 75 mM phosphoric acid, and the solution is passed through a 2.5-cm phosphocellulose filter disk that binds the peptide. The filter is washed five times with 75 mM phosphoric acid and placed in a vial with 5 mL of scintillation fluid. The uninhibited control activity produces approximately 100,000 cpm. |
体外活性 | 作用于HFD-fed小鼠时,PD153035促进耐糖量、胰岛素敏感性和信号,并使亚临床炎症降低.作用于携带A431人体表皮样癌细胞移植瘤的免疫缺陷裸鼠,PD153035(80 mg/kg)对EGF受体酪氨酸激酶活性有抑制作用. |
体内活性 | PD153035剂量依赖性地抑制鼻咽癌细胞系HONE1(IC50:18.6 μM),NPC-TW04(IC50:9.8 μM)和NPC-TW01(IC50:12.9 μM)。PD153035抑制A-431人扁平上皮癌相关的表皮生长因子受体酪氨酸激酶(Ki:5.2 pM,IC50:29 pM)。作用于Caco-2结肠癌细胞时,PD153035可使PAR(2)激活肽2-呋喃甲酰基-LIGRLO-NH(2)(2fLI)诱导的COX-2表达沉默。作用于Swiss 3T3成纤维细胞和A-431人扁平上皮癌细胞时,PD153035可选择性抑制EGF诱导的酪氨酸磷酸化(IC50:15 nM和14 nM)。作用于过量表达EGF受体的人癌细胞系时,PD153035抑制包括A431, DU145, Difi, ME180和MDA-MB-468在内的细胞生长,IC50分别为0.22 μM, 0.4 μM, 0.3 μM, 0.95 μM和0.68 μM。 |
存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 4 mg/mL (10 mM), Heating is recommended.
|
关键字 | Inhibitor | SU-5271 | HER1 | PD-153035 | ErbB-1 | PD153035 hydrochloride | ZM-252868 | PD153035 Hydrochloride | PD-153035 Hydrochloride | Epidermal growth factor receptor | PD153035 | SU5271 | PD 153035 | Tyrphostin AG-1517 | ZM252868 | EGFR | inhibit | PD 153035 Hydrochloride | AG1517 | PD-153035 hydrochloride | AG-1517 | Tyrphostin AG1517 |
相关产品 | Lapatinib | Neratinib | Chalcone | Gefitinib | Erlotinib | Osimertinib | Erlotinib hydrochloride | Afatinib Dimaleate | Lidocaine Hydrochloride hydrate | Genistein | Khellin | Osimertinib mesylate |
相关库 | 抑制剂库 | 血管生成库 | 经典已知活性库 | 抗癌活性化合物库 | 已知活性化合物库 | 抗胰腺癌化合物库 | 激酶抑制剂库 | 临床前化合物库 | 膜蛋白靶向化合物库 | 酪氨酸激酶分子库 |